Merck KGaA Acquires Supplier to Biopharma Industry in China
Merck KGaA announced that it has acquired 100% of the share capital of Beijing Skywing Technology Co., Ltd., a supplier of cell-culture media products, related technical services and bioreactors for the Chinese biopharmaceutical industry. The company is headquartered in the Changping district of Beijing and currently employs 80 people. The purchase price was CYN 120 million (approx. EUR 14 million).
“The acquisition allows Merck to immediately establish a direct presence in this market segment in China with access to an attractive and innovative cell-culture media portfolio, close relationships to local customers, a skilled management team and a high-quality facility. These capabilities will enable Merck Millipore Process Solutions to strengthen the upstream processing offer to customers in China so that they can manufacture biopharmaceuticals safely and efficiently,” said Burghard Freiberg, Head of the Business Field Pharm Chemicals Solutions of the Merck Millipore division.
“Beijing Skywing Technology is one of the leading players in the cell-culture media market in China with very close business relationships to vaccine manufacturers and an excellent reputation in the local biotech industry. In addition, this access to the Chinese biopharmaceutical market can be utilized to leverage other Merck Millipore consumables sales like chromatography media, filtration devices and disposable bioreactor solutions,” added Dr. Matthias Bucerius, Head of Sales Asia, Pharm Chemicals Solutions of the Merck Millipore division.
Other news from the department business & finance
These products might interest you

CHOventure Growth Medium by Capricorn Scientific
High-Yield Protein Production with CHO Cells for Biopharmaceutical Applications
Optimized for High-Density Cultures and Enhanced Protein Yields in CHO Cell Bioprocessing

HEK Media by Sartorius
Serum-free cell culture media for HEK cells
Optimised for HEK293 cells and viral vector production, ISO 9001 certified

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Cell culture technology
Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.

Topic world Cell culture technology
Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.